Register-based studies of delivery outcome after maternal use of some common drugs
Author: Wikner, Birgitta Norstedt
Date: 2008-11-28
Location: Skandiasalen Astrid Lindgrens Barnsjukhus
Time: 09.30
Department: Institutionen för medicin / Department of Medicine
View/ Open:
thesis.pdf (840.3Kb)
Abstract
This thesis aimed to study neonatal outcome including the presence of
congenital malformations and to describe maternal characteristics for
women using some common drugs during pregnancy. Drugs used in one benign
condition (nausea and vomiting) and one chronic disease (hypothyroidism)
and the CNS-active drugs benzodiazepines and hypnotic benzodiazepine
receptor agonists were selected.
The studies were based on the Swedish Medical Birth Register (MBR). The main advantages with MBR are that relatively large numbers of exposed women and their infants can be identified (coverage 98- 99% of deliveries in Sweden). Drug exposure as well as information about putative confounders are based on information retrieved early in pregnancy, before the birth of the child, and are therefore prospective. The information on the outcome is based on medical documents and is basically not affected by the exposure. Some weaknesses in MBR are that interview data will probably understate drug use, drugs may be taken but not reported/recorded, the indication for drug use is often not known and the information of exact duration and dosage is often incomplete. Further, the studies are based on born infants, aborted foetuses are not included.
Pregnant women exposed to antiemetic drugs, a surrogate marker for nausea and vomiting during pregnancy, showed an overall better neonatal outcome including prevalence at birth of malformations in the infants. For some antiemetic drugs the number of exposures was low. Young maternal age, non-smoking, low education, parity >=2, were characteristics of women exposed to antiemetic drugs. There was an excess of girls and twins among born infants.
Women using benzodiazepines or hypnotic benzodiazepine receptor agonists during pregnancy differ in many aspects from non-users. These differences may act as confounders in the analysis of pregnancy outcome, and were adjusted for. An increased risk for preterm birth, low birth weight and when exposed late during pregnancy also an increased risk for respiratory problems was seen in neonates. The teratogenic potential does not appear to be strong, but a higher than expected number of infants with pylorostenosis or alimentary tract atresia (especially small gut) was found. No increased risk for orofacial clefts was found.
Women substituted with thyroid hormones during pregnancy had diabetes co-morbidity more often than expected as well as co-medication with, e.g., cardiovascular drugs, systemic corticosteroids and psychiatric drugs. Subfertility, previous miscarriage, pre-eclampsia, caesarean section and induction of labour were more common than in non-users. Neonates were only slightly affected, although a marginal increased risk for premature birth, increased rates of neonatal thyroid disease and a slightly increased rate of malformations was found.
In conclusion, the Swedish Medical Birth Register has advantages and disadvantages but is a powerful tool for surveillance and assessment of teratogenic risks. However, possible associations found are hypothesis generating and need to be confirmed or rejected in new studies.
The studies were based on the Swedish Medical Birth Register (MBR). The main advantages with MBR are that relatively large numbers of exposed women and their infants can be identified (coverage 98- 99% of deliveries in Sweden). Drug exposure as well as information about putative confounders are based on information retrieved early in pregnancy, before the birth of the child, and are therefore prospective. The information on the outcome is based on medical documents and is basically not affected by the exposure. Some weaknesses in MBR are that interview data will probably understate drug use, drugs may be taken but not reported/recorded, the indication for drug use is often not known and the information of exact duration and dosage is often incomplete. Further, the studies are based on born infants, aborted foetuses are not included.
Pregnant women exposed to antiemetic drugs, a surrogate marker for nausea and vomiting during pregnancy, showed an overall better neonatal outcome including prevalence at birth of malformations in the infants. For some antiemetic drugs the number of exposures was low. Young maternal age, non-smoking, low education, parity >=2, were characteristics of women exposed to antiemetic drugs. There was an excess of girls and twins among born infants.
Women using benzodiazepines or hypnotic benzodiazepine receptor agonists during pregnancy differ in many aspects from non-users. These differences may act as confounders in the analysis of pregnancy outcome, and were adjusted for. An increased risk for preterm birth, low birth weight and when exposed late during pregnancy also an increased risk for respiratory problems was seen in neonates. The teratogenic potential does not appear to be strong, but a higher than expected number of infants with pylorostenosis or alimentary tract atresia (especially small gut) was found. No increased risk for orofacial clefts was found.
Women substituted with thyroid hormones during pregnancy had diabetes co-morbidity more often than expected as well as co-medication with, e.g., cardiovascular drugs, systemic corticosteroids and psychiatric drugs. Subfertility, previous miscarriage, pre-eclampsia, caesarean section and induction of labour were more common than in non-users. Neonates were only slightly affected, although a marginal increased risk for premature birth, increased rates of neonatal thyroid disease and a slightly increased rate of malformations was found.
In conclusion, the Swedish Medical Birth Register has advantages and disadvantages but is a powerful tool for surveillance and assessment of teratogenic risks. However, possible associations found are hypothesis generating and need to be confirmed or rejected in new studies.
List of papers:
I. Asker C, Norstedt Wikner B, Källén B (2005). "Use of antiemetic drugs during pregnancy in Sweden." Eur J Clin Pharmacol 61(12): 899-906. Epub 2005 Nov 18
Pubmed
II. Wikner BN, Stiller CO, Källén B, Asker C (2007). "Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: maternal characteristics." Pharmacoepidemiol Drug Saf 16(9): 988-94
Pubmed
III. Wikner BN, Stiller CO, Bergman U, Asker C, Källén B (2007). "Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations." Pharmacoepidemiol Drug Saf 16(11): 1203-10
Pubmed
IV. Wikner BN, Sparre LS, Stiller CO, Källén B, Asker C (2008). "Maternal use of thyroid hormones in pregnancy and neonatal outcome." Acta Obstet Gynecol Scand 87(6): 617-27
Pubmed
I. Asker C, Norstedt Wikner B, Källén B (2005). "Use of antiemetic drugs during pregnancy in Sweden." Eur J Clin Pharmacol 61(12): 899-906. Epub 2005 Nov 18
Pubmed
II. Wikner BN, Stiller CO, Källén B, Asker C (2007). "Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: maternal characteristics." Pharmacoepidemiol Drug Saf 16(9): 988-94
Pubmed
III. Wikner BN, Stiller CO, Bergman U, Asker C, Källén B (2007). "Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations." Pharmacoepidemiol Drug Saf 16(11): 1203-10
Pubmed
IV. Wikner BN, Sparre LS, Stiller CO, Källén B, Asker C (2008). "Maternal use of thyroid hormones in pregnancy and neonatal outcome." Acta Obstet Gynecol Scand 87(6): 617-27
Pubmed
Issue date: 2008-11-07
Rights:
Publication year: 2008
ISBN: 978-91-7409-059-8
Statistics
Total Visits
Views | |
---|---|
Register-based ...(legacy) | 770 |
Register-based ... | 131 |
Total Visits Per Month
September 2023 | October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | |
---|---|---|---|---|---|---|---|
Register-based ... | 0 | 4 | 1 | 1 | 1 | 0 | 1 |
File Visits
Views | |
---|---|
thesis.pdf(legacy) | 482 |
thesis.pdf | 127 |
thesis.pdf.txt(legacy) | 2 |
Top country views
Views | |
---|---|
United States | 340 |
China | 74 |
Germany | 69 |
Sweden | 61 |
Finland | 17 |
United Kingdom | 14 |
South Korea | 14 |
Russia | 12 |
Saudi Arabia | 10 |
Ireland | 9 |
Top cities views
Views | |
---|---|
Sunnyvale | 43 |
Romeo | 31 |
Beijing | 24 |
Kiez | 21 |
Seoul | 14 |
Nürnberg | 12 |
University Park | 12 |
Riyadh | 10 |
Shenzhen | 10 |
Helsinki | 9 |